ALPN - Alpine Immune Sciences GAAP EPS of -$0.28 beats by $0.12 revenue of $7.03M beats by $3.51M
2024-05-09 17:50:00 ET
More on Alpine Immune Sciences
- Alpine: Vertex Acquisition Brings About More Than IgA Nephropathy Advancement
- What Vertex Pharmaceuticals Is Getting With Acquisition Of Alpine Immune Sciences
- Vertex To Buy Alpine Immune - Why This Deal Feels Slightly 'Vanilla'
- Vertex Pharma upgraded at Evercore on Alpine Immune deal
- Vertex enters into agreement to acquire Alpine Immune Sciences